Negative impact of Interleukin-9 on synovial regulatory T cells in rheumatoid arthritis

Clin Immunol. 2023 Dec:257:109814. doi: 10.1016/j.clim.2023.109814. Epub 2023 Oct 23.

Abstract

In Rheumatoid Arthritis (RA), regulatory T cells (Tregs) have been found to be enriched in the synovial fluid. Despite their accumulation, they are unable to suppress synovial inflammation. Recently, we showed the synovial enrichment of interleukin-9 (IL-9) producing helper T cells and its positive correlation with disease activity. Therefore, we investigated the impact of IL-9 on synovial Tregs in RA. Here, we confirmed high synovial Tregs in RA patients, however these cells were functionally impaired in terms of suppressive cytokine production (IL-10 and TGF-β). Abrogating IL-9/ IL-9 receptor interaction could restore the suppressive cytokine production of synovial Tregs and reduce the synovial inflammatory T cells producing IFN-γ, TNF-α, IL-17. However, blocking these inflammatory cytokines failed to show any effect on IL-9 producing T cells, highlighting IL-9's hierarchy in the inflammatory network. Thus, we propose that blocking IL-9 might dampen synovial inflammation by restoring Tregs function and inhibiting inflammatory T cells.

Keywords: Inflammatory cytokines; Interleukin −9; Regulatory T cells; Rheumatoid arthritis; Synovial fluid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arthritis, Rheumatoid* / metabolism
  • Cytokines
  • Humans
  • Inflammation
  • Interleukin-9* / metabolism
  • Synovial Fluid
  • Synovial Membrane
  • T-Lymphocytes, Regulatory* / metabolism

Substances

  • Cytokines
  • Interleukin-9